prescription drug prices

Report Slams 340B Drug Discount ProgramA Pacific Research Institute report revealed that the 340B program is in desperate need of reform, while 340B Health refutes damaging claims.
Is there a simple fix for the Part D discount program?A poll from the Biosimilars Council, a division of the Association for Accessible Medicines, has interesting findings about placing biosimilars and branded biologics on a level playing field to save money.
How a New Technology Can Keep Pharmacists in the Front LinesSurescripts has unveiled a new prescription benefit and prior authorization solution.
When someone else pays, Rx costs soarWhy are Rx drugs so expensive? No one seems to have a good answer.
Senate to conduct investigation into Rx drug pricingThe U.S. Senate will conduct a bipartisan investigation into pharmaceutical drug prices following recent public and political outrage over drastic price increases for certain drugs.
Oncologists not prescribing expensive cancer drugsIn the latest controversy over the high cost of certain prescription medications, a recent Reuters article said that more oncologists won’t prescribe expensive drugs.
Rising Rx prices front and center in presidential campaignFollowing public outrage over price increases for two specialty drugs, the frontrunners for the Democratic nomination for president are both pushing plans to lower the costs of prescription drugs.
Americans support government action to lower Rx pricesMore than 7 out of 10 Americans believe that drug costs are unreasonable and drug companies place profits before people, according to a recent Kaiser Health Tracking poll.
5 drugs headed for $1B or more in sales by 2020Global prescription drug sales should reach nearly $1 trillion by 2020, thanks in part to FDA approvals of breakthrough drugs for cancer, hepatitis C and other diseases, a new report finds.
High healthcare costs driven by spike in Rx costsA significant spike in prescription drug costs helped drive healthcare costs for families covered under an average employer's health insurance plan up an estimated 6.3% in 2015, according to the Milliman Medical Index (MMI) report.